Citation

Certal V, Halley F, Virone-Oddos A, Thompson F, Filoche-Rommé B, El-Ahmad Y, Carry JC, Delorme C, Karlsson A, Abecassis PY, Vincent L, Bonnevaux H, Nicolas JP, Morales R, Michot N, Vade I, Louboutin A, Perron S, Doerflinger G, Tric B, Monget S, Lengauer C, Schio L.: Preparation and optimization of new 4-(morpholin-4-yl)-(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives as PI3Kβ inhibitors. Bioorg Med Chem Lett, Volume 22 (20), 2012

Authors

Abecassis PY, Bonnevaux H, Carry JC, Certal V, Delorme C, Doerflinger G, El-Ahmad Y, Filoche-Rommé B, Halley F, Karlsson A, Lengauer C, Louboutin A, Michot N, Monget S, Morales R, Nicolas JP, Perron S, Schio L., Thompson F, Tric B, Vade I, Vincent L, Virone-Oddos A

Journal

Bioorg Med Chem Lett

Year

2012

DOI

10.1016/j.bmcl.2012.08.072

PubMed

22981333

Machine-readable

REST APIRDF